NanoString to Present at the 2019 Morgan Stanley Global Healthcare Conference
August 28, 2019 06:00 ET
|
NanoString Technologies, Inc.
SEATTLE, Aug. 28, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research and molecular diagnostic products, today...
NanoString to Present at the Baird 2019 Global Healthcare Conference
August 19, 2019 06:00 ET
|
NanoString Technologies, Inc.
SEATTLE, Aug. 19, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research and molecular diagnostic products, today...
New Publication Demonstrates First Use of NanoString’s GeoMx Digital Spatial Profiler in Neuroscience
August 06, 2019 06:00 ET
|
NanoString Technologies, Inc.
SEATTLE, Aug. 06, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced...
NanoString Technologies Releases Operating Results for Second Quarter of 2019
July 31, 2019 16:01 ET
|
NanoString Technologies, Inc.
SEATTLE, July 31, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today reported...
NanoString Technologies and Mayo Clinic Laboratories Enter Joint Development Agreement to Develop Novel Assays
July 30, 2019 09:29 ET
|
NanoString Technologies, Inc.
SEATTLE and ROCHESTER, Minn., July 30, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies and Mayo Clinic Laboratories have announced a collaboration to develop clinical tests using NanoString's new...
CORRECTING and REPLACING - Nature Medicine Publication Highlights use of the GeoMx Digital Spatial Profiler to Characterize Mechanism of Neurotoxicity in Immuno-Therapy
July 23, 2019 15:20 ET
|
NanoString Technologies, Inc.
SEATTLE, July 23, 2019 (GLOBE NEWSWIRE) -- In a release issued yesterday by NanoString Technologies, Inc. (NASDAQ:NSTG) under the same headline, please note that in the third paragraph Dr. Justin...
Nature Medicine Publication Highlights use of the GeoMx Digital Spatial Profiler to Characterize Mechanism of Neurotoxicity in Immuno-Therapy
July 22, 2019 16:01 ET
|
NanoString Technologies, Inc.
SEATTLE, July 22, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced...
NanoString Collaborates with MODEL-AD Consortium to Accelerate Alzheimer’s Disease Research
July 15, 2019 06:00 ET
|
NanoString Technologies, Inc.
nCounter Mouse AD Gene Expression Panel Applied to Characterize Five Novel Mouse Models New nCounter Human AD Gene Expression Panel Launched at AAIC 2019 SEATTLE, July 15, 2019 (GLOBE...
NanoString to Release Second Quarter 2019 Financial Results and Host Conference Call on Wednesday, July 31, 2019
July 10, 2019 06:00 ET
|
NanoString Technologies, Inc.
SEATTLE, July 10, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced...
Publication in the Journal Clinical Cancer Research Uses NanoString’s GeoMx Digital Spatial Profiler to Discover Predictive Biomarkers for Immunotherapy
June 18, 2019 16:01 ET
|
NanoString Technologies, Inc.
SEATTLE, June 18, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced...